CIM Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $771K | Buy |
10,123
+5,053
| +100% | +$385K | 0.15% | 132 |
|
|
2025
Q1 | $367K | Sell |
5,070
-4
| -0.1% | -$290 | 0.08% | 146 |
|
|
2024
Q4 | $376K | Sell |
5,074
-25
| -0.5% | -$1.85K | 0.11% | 154 |
|
|
2024
Q3 | $336K | Sell |
5,099
-145
| -3% | -$9.57K | 0.1% | 173 |
|
|
2024
Q2 | $484K | Sell |
5,244
-48
| -0.9% | -$4.43K | 0.15% | 129 |
|
|
2024
Q1 | $506K | Hold |
5,292
| – | – | 0.15% | 133 |
|
|
2023
Q4 | $404K | Hold |
5,292
| – | – | 0.13% | 160 |
|
|
2023
Q3 | $367K | Sell |
5,292
-133
| -2% | -$9.21K | 0.13% | 155 |
|
|
2023
Q2 | $512K | Buy |
5,425
+12
| +0.2% | +$1.13K | 0.17% | 118 |
|
|
2023
Q1 | $448K | Buy |
5,413
+238
| +5% | +$19.7K | 0.17% | 130 |
|
|
2022
Q4 | $386K | Buy |
+5,175
| New | +$386K | 0.15% | 137 |
|
|
2022
Q3 | – | Sell |
-4,637
| Closed | -$441K | – | 228 |
|
|
2022
Q2 | $441K | Sell |
4,637
-42
| -0.9% | -$3.99K | 0.18% | 118 |
|
|
2022
Q1 | $551K | Sell |
4,679
-4
| -0.1% | -$471 | 0.19% | 110 |
|
|
2021
Q4 | $607K | Sell |
4,683
-83
| -2% | -$10.8K | 0.18% | 121 |
|
|
2021
Q3 | $540K | Sell |
4,766
-46
| -1% | -$5.21K | 0.17% | 126 |
|
|
2021
Q2 | $498K | Buy |
+4,812
| New | +$498K | 0.15% | 142 |
|